BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 37762660)

  • 1. Exosomes in the Diagnosis and Treatment of Renal Cell Cancer.
    Boussios S; Devo P; Goodall ICA; Sirlantzis K; Ghose A; Shinde SD; Papadopoulos V; Sanchez E; Rassy E; Ovsepian SV
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes in renal cell carcinoma: challenges and opportunities.
    Mohammadi M; Mansouri K; Mohammadi P; Pournazari M; Najafi H
    Mol Biol Rep; 2024 Mar; 51(1):443. PubMed ID: 38520545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Vesicles in Renal Cell Carcinoma: Multifaceted Roles and Potential Applications Identified by Experimental and Computational Methods.
    Qin Z; Xu Q; Hu H; Yu L; Zeng S
    Front Oncol; 2020; 10():724. PubMed ID: 32457844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
    Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
    Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the research of exosomes in renal cell carcinoma: from mechanisms to applications.
    Rui R; Zhou L; He S
    Front Immunol; 2023; 14():1271669. PubMed ID: 37942325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes and extracellular vesicles: Rethinking the essential values in cancer biology.
    Yokoi A; Ochiya T
    Semin Cancer Biol; 2021 Sep; 74():79-91. PubMed ID: 33798721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of tumor-derived exosomes in metastasis, drug resistance and diagnosis of clear cell renal cell carcinoma.
    Jiang T; Zhu Z; Zhang J; Chen M; Chen S
    Front Oncol; 2022; 12():1066288. PubMed ID: 36620603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro.
    Zieren RC; Dong L; Clark DJ; Kuczler MD; Horie K; Moreno LF; Lih TM; Schnaubelt M; Vermeulen L; Zhang H; de Reijke TM; Pienta KJ; Amend SR
    Med Oncol; 2021 Jul; 38(9):105. PubMed ID: 34331598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Roles of Extracellular Vesicles in the Progression of Renal Cell Carcinoma and Their Potential for Future Clinical Application.
    Takeda M; Akamatsu S; Kita Y; Goto T; Kobayashi T
    Nanomaterials (Basel); 2023 May; 13(10):. PubMed ID: 37242027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles in renal cell carcinoma: challenges and opportunities coexist.
    Lu Y; Zhang M; Zhou J; Liu X; Wang L; Hu X; Mao Y; Gan R; Chen Z
    Front Immunol; 2023; 14():1212101. PubMed ID: 37469514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic effects of RAB27B through exosome independent function in renal cell carcinoma including sunitinib-resistant.
    Tsuruda M; Yoshino H; Okamura S; Kuroshima K; Osako Y; Sakaguchi T; Sugita S; Tatarano S; Nakagawa M; Enokida H
    PLoS One; 2020; 15(5):e0232545. PubMed ID: 32379831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal Cell Carcinoma with Advanced Clinicopathological Features.
    Horie K; Kawakami K; Fujita Y; Matsuda Y; Arai T; Suzui N; Miyazaki T; Koie T; Mizutani K; Ito M
    Oncology; 2020; 98(10):734-742. PubMed ID: 32726790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolites as extracellular vesicle cargo in health, cancer, pleural effusion, and cardiovascular diseases: An emerging field of study to diagnostic and therapeutic purposes.
    Zhang Y; Liang F; Zhang D; Qi S; Liu Y
    Biomed Pharmacother; 2023 Jan; 157():114046. PubMed ID: 36469967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicle communication pathways as regulatory targets of oncogenic transformation.
    Choi D; Lee TH; Spinelli C; Chennakrishnaiah S; D'Asti E; Rak J
    Semin Cell Dev Biol; 2017 Jul; 67():11-22. PubMed ID: 28077296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Extracellular Vesicles (EVs) in Cell Stress Response and Resistance to Cancer Therapy.
    O'Neill CP; Gilligan KE; Dwyer RM
    Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30682793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy.
    Aghakhani A; Pezeshki PS; Rezaei N
    Expert Opin Investig Drugs; 2024 May; ():1-20. PubMed ID: 38795060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes-Promising Carriers for Regulatory Therapy in Oncology.
    Jóźwicka TM; Erdmańska PM; Stachowicz-Karpińska A; Olkiewicz M; Jóźwicki W
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma-derived exosomes: Versatile extracellular vesicles for diagnosis, metastasis, immune modulation, and treatment of melanoma.
    Alia Moosavian S; Hashemi M; Etemad L; Daneshmand S; Salmasi Z
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109320. PubMed ID: 36274482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular actions of exosomes and their theragnostics in colorectal cancer: current findings and limitations.
    Lin WC; Lin CC; Lin YY; Yang WH; Twu YC; Teng HW; Hwang WL
    Cell Oncol (Dordr); 2022 Dec; 45(6):1043-1052. PubMed ID: 36048363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.